1-3 of 3
Taisei Kinoshita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Irreversible Menin Inhibitor, BMF-219, Shows Potent Single Agent Activity in Clinically Relevant DLBCL Cells

Priyanka Somanath, Daniel Lu, Brian Law, Tenley C. Archer, Alexandru Cacovean, James T. Palmer, Taisei Kinoshita, Thomas Butler
Journal: Blood
Blood (2021) 138 (Supplement 1): 4318.
https://doi.org/10.1182/blood-2021-148045
Published: 2021
Journal Articles

Kinetic Catalytic Inhibition and Cell-Based Analysis, Not Just Target Binding, Are Required to Assess Kinase Selectivity of Covalent Inhibitors: Comparable BTK vs TEC Selectivity Profile for Ibrutinib and Acalabrutinib

Melissa Hopper, MS, Tarikere Gururaja, PhD, Taisei Kinoshita, PhD, James P. Dean, Ronald Hill, PhD, Ann Mongan, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3498.
https://doi.org/10.1182/blood-2018-99-110849
Published: 2018
Journal Articles

Cultivation of aorta-gonad-mesonephros–derived hematopoietic stem cells in the fetal liver microenvironment amplifies long-term repopulating activity and enhances engraftment to the bone marrow

Masaki Takeuchi, Takashi Sekiguchi, Takahiko Hara, Taisei Kinoshita, Atsushi Miyajima
Journal: Blood
Blood (2002) 99 (4): 1190–1196.
https://doi.org/10.1182/blood.V99.4.1190
Published: 2002